ICAM-1 (ICRT)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameICAM-1 (ICRT)
Drug Alias NameLFA (ICRT)ICAM-1LFA
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunosuppressantsIntercellular adhesion molecule-1 stimulants
TargetsIntercellular adhesion molecule-1
Therapy Area/IndicationsRejection of organ transplantationHematopoietic stem cell transplantation (HSCT)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImperial Cancer Research Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImperial Cancer Research Technology
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationHematopoietic stem cell transplantation (HSCT)

Other Information

ATC CodeN/A
Related LinksN/A